Overview


Amifostine, also known by its brand name Ethyol, is a medication used in cancer treatment and certain medical procedures to reduce the toxic effects of chemotherapy drugs and radiation therapy on healthy tissues. It belongs to a class of drugs called cytoprotective agents. These agents are designed to help protect normal cells from the harmful effects of cancer treatments, which can inadvertently damage healthy tissues while targeting cancer cells.

Amifostine works by acting as a scavenger for harmful free radicals and reactive oxygen molecules that are generated as a result of chemotherapy and radiation therapy. These free radicals can cause damage to tissues, cells and DNA, contributing to side effects such as nausea, vomiting, fatigue, and damage to the mucous membranes and other healthy tissues. Amifostine is administered intravenously (IV) before chemotherapy or radiation therapy. The aim is to decrease the negative impact of cancer treatment on healthy cells by neutralizing the harmful effects of free radicals. As a result, patients may experience less severe side effects and an overall better treatment experience, leading to an improved quality of life.

FutureWise Market Research has published a report that provides an insightful analysis of Amifostine Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Amifostine Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Clinigen
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

(Note: The list of the major players will be updated with the latest market scenario and trends)

The key factor fuelling the market is the escalating incidence of cancer on a global scale necessitates effective measures to alleviate the adverse effects of cancer treatments. Amifostine's role as a cytoprotective agent makes it crucial in safeguarding healthy tissues from the harmful impact of chemotherapy and radiation therapies. As cancer cases rise, the demand for such supportive care medications increases, enhancing patients' well-being during their treatment journeys. Additionally, the continuous advancements in cancer treatment approaches, such as targeted therapies and immunotherapies, result in treatments that can be harsh on healthy cells. Amifostine's ability to mitigate these treatment-related toxicities positions it as an essential component in modern cancer care. Also, the growing awareness among healthcare professionals about the benefits of using amifostine contributes to its wider integration into treatment protocols. This heightened awareness ensures that the medication's potential is harnessed to minimize discomfort and enhance patient outcomes. Moreover, the shift towards patient-centric care emphasizes the importance of minimizing treatment-related discomfort, a goal amifostine successfully addresses. Moreover, the paradigm of personalized medicine introduces the opportunity to tailor amifostine's application based on individual patient profiles, optimizing its effectiveness and minimizing side effects. In emerging markets, improving healthcare infrastructure presents fertile ground for the adoption of advanced supportive care therapies like amifostine, opening doors for market expansion. Collaborations between pharmaceutical companies, research institutions, and healthcare providers offer the potential for synergistic advancements, leveraging amifostine's capabilities in combination with innovative treatment approaches. However, despite growing awareness, amifostine's benefits might not be universally recognized, limiting its widespread utilization. Its potential side effects and suitability for specific patients or treatments are expected to limit its broad application. The economic aspect also plays a role, as the cost of amifostine treatment and reimbursement policies could restrict access for patients, especially in regions with financial constraints.

By Type

  • 400mg/Dose
  • 500mg/Dose

By Application

  • Head and Neck Cancer Adjuvant Therapy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The region experiences a significant burden of cancer cases, driving the demand for effective supportive care measures. The need to improve the quality of life for cancer patients undergoing aggressive treatments aligns with amifostine's cytoprotective properties. North America boasts a highly developed healthcare infrastructure, enabling efficient integration of innovative treatments like amifostine into clinical practice. This infrastructure facilitates early adoption and accessibility of advanced supportive care therapies. North America's strong emphasis on medical research and clinical trials provides a platform for testing and validating the effectiveness of amifostine across various cancer types, and treatment regimens is expected to drive market demand in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Amifostine Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Amifostine Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amifostine Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Amifostine Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Amifostine Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. 400mg/Dose
        2. 500mg/Dose

  • 8.   Amifostine Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Head and Neck Cancer Adjuvant Therapy
        2. Others

  • 9.   North America Amifostine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Amifostine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Amifostine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Amifostine Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Clinigen
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Sun Pharmaceutical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Taj Pharmaceuticals
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merro Pharmaceutical
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Luye Pharma
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mingren Pharma
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11